US Broker Ratings

IDEAYA Biosciences (IDYA) Stock Analysis: A Promising Upside of 38.69% in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a prominent player in the biotechnology sector, is making waves with its innovative approach to precision medicine oncology. With a market capitalization of $3.14 billion,..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Navigating Potential Upside in the Medical Devices Market

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With its headquarters in San Diego, California, Tandem focuses..

Mesoblast Limited (MESO) Stock Analysis: 100% Upside Potential in Biotech Breakthrough

Mesoblast Limited (MESO), an Australian biotechnology company, is capturing the attention of investors with a staggering potential upside of 100.57%. Specializing in regenerative medicine, Mesoblast is leveraging its proprietary technology..

Indivior PLC (INDV) Investor Outlook: A 35.66% Potential Upside with Strong Buy Ratings

Indivior PLC (INDV), a prominent player in the healthcare sector, is capturing significant investor attention with its robust position in the drug manufacturing industry, particularly in specialty and generic pharmaceuticals...

Clover Health Investments, Corp (CLOV) Stock Analysis: Unpacking a 27.3% Potential Upside

For investors eyeing the healthcare sector, Clover Health Investments, Corp (NASDAQ: CLOV) presents a mix of challenges and opportunities. With a market capitalization of $1.31 billion, Clover Health stands as..

AtriCure, Inc. (ATRC) Stock Analysis: A Promising 35% Upside Potential Amid Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity for those seeking exposure to the rapidly advancing..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 50% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on rare kidney and metabolic diseases, has become a compelling point of interest for investors, showcasing a potential upside of 50.44%..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 6.43% Potential Upside in a Dynamic Healthcare Landscape

Bausch Health Companies Inc. (BHC), a prominent player in the healthcare sector, operates a diversified portfolio that spans specialty pharmaceuticals and medical devices. With a market capitalization of $2.59 billion,..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech Gem with a 27.70% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a rising star in the biotechnology sector, is captivating investor attention with its promising pipeline and a substantial upside potential of 27.70%, according to analyst..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Growth in Senior Care with a 7.58% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, is making waves in the medical care facilities industry with its robust portfolio of senior living communities...

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Powerhouse with 41.87% Potential Upside

CG Oncology, Inc. (CGON) is making waves in the biotechnology sector, drawing significant attention from investors with its robust pipeline of bladder cancer treatments. Headquartered in Irvine, California, this late-stage..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 48.90% Potential Upside in Healthcare Innovation

Schrödinger, Inc. (NASDAQ: SDGR) stands at the intersection of healthcare and technology, offering compelling prospects for individual investors. With a current market capitalization of $1.24 billion, this New York-based player..

NewAmsterdam Pharma (NAMS) Stock Analysis: Evaluating the 52.72% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a notable player in the biotechnology sector, has captured investor attention with its promising potential upside of 52.72%. This Dutch biopharmaceutical firm is dedicated to..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 58% Potential Upside in the Genomics Space

GeneDx Holdings Corp. (NYSE: WGS) stands at the forefront of the healthcare sector’s promising genomics industry, with its specialized focus on genetic testing services. As a company with a significant..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 39% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, presents an intriguing opportunity for investors focused on innovative healthcare solutions. With a market capitalization of $2.9 billion,..

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 19.79% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a significant player in the healthcare sector, has captured investor attention with its robust growth potential and operational footprint across the United States. As..

Denali Therapeutics Inc. (DNLI)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook with 207% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, is making waves with its promising pipeline and remarkable potential upside. Specializing in the development of oral small-molecule..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking a 24% Upside Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) continues to capture the attention of investors with its innovative approach to fertility and family-building benefits. As a healthcare plans provider specializing in fertility solutions, Progyny..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 67.91% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has captured investor attention with its innovative approach in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Watertown, Massachusetts, is pioneering in the field..

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds